Irloxacin

Research use only, not for human use.

Irloxacin is a new quinolone derivative, and shows greater activity with an acid pH. Irloxacin has a good in vitro antimicrobial spectrum against both gram-positive and gram-negative bacteria.

Irloxacin is a new quinolone derivative, and shows greater activity with an acid pH. Irloxacin has a good in vitro antimicrobial spectrum against both gram-positive and gram-negative bacteria.(In Vitro):We have compared the in vitro activity of irloxacin against mycobacteria (20 M. tuberculosis, 17 M. avium, 5 Mycobacterium bovis, 5 Mycobacterium chelonae, 5 Mycobacterium fortuitum and 1 Mycobacterium gadium) using the Bactec at pH 6.8 and 5.0, with other quinolones (ofloxacin, ciprofloxacin, pefloxacin and 27753 RP). All quinolones tested showed good activity against mycobacteria at pH 6.8 and 5.0. Irloxacin at pH 5.0 had a greater activity against M. avium.

——

——

Pirfloxacin

GPCR/G Protein

Antibacterial

A2B

——

——

91524-15-1

300.28

C16H13FN2O3

>98% (HPLC)

In Vitro:?DMSO : 33.33 mg/mL (111.00 mM)

CCN(C=C(C(O)=O)C(c1c2)=O)c1cc(-n1cccc1)c2F

——

(-20℃)

With Ice Pack

≥ 2 years